This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pagotto, U. Articles by Stalla, G. K. Search for Related Content PubMed PubMed Citation Articles by Pagotto, U. Articles by Stalla, G. K.

Inhibition of Zac1, a New Gene Differentially Expressed in the Anterior Pituitary, Increases Cell Proliferation¹

Max Planck Institute of Psychiatry (U.P., E.C., F.L., D.S., G.K.S.), 80804 Munich; and the Departments of Neurology, Technical University of Munich (T.A.), 81675 Munich, Germany; Centre National de la Recherche Scientifique (L.J., D.S.), 34094 Montpellier Cedex 05, France; and the Institute of Semeiotica Medica, University of Padua (C.P.), Padua, Italy

Address all correspondence and requests for reprints to: Uberto Pagotto, M.D., Department of Endocrinology, Max Planck Institute of Psychiatry, Kraepelinstrasse 10, 80804 Munich, Germany. E-mail: pagotto{at}mpipsykl.mpg.de

Zac1 is a new zinc finger protein that concomitantly controls apoptosis and cell cycle arrest through separate pathways. The mouse Zac1 gene is mainly expressed in the pituitary gland and in different brain areas. In this study regional and cellular expression of Zac1 in the pituitary gland was determined by in situ hybridization. Zac1 messenger RNA was abundantly expressed in the anterior pituitary lobe compared with that in the intermediate and posterior lobes. Zac1 transcripts were found in all hormone-secreting cell types, with the highest levels in GH- and PRL-producing cells.

To investigate the impact of Zac1 in pituitary cell proliferation, we ablated the endogenous Zac1 gene by antisense treatment in two murine cell types, AtT-20 and TtT/GF, that are representative of granular and agranular cell lineages, respectively. The decline in Zac1 protein levels under antisense treatment was accompanied by increased DNA synthesis in clonal corticotroph and folliculo-stellate cells, as demonstrated by enhanced [³H]thymidine incorporation (36% and 50%, respectively). Antisense oligonucleotides against Zac1 controlled cell proliferation in a dose-dependent way, and mutagenized antisense oligonucleotides were inert. Conclusively, our data provide the first evidence of a role for Zac1 in pituitary growth control.

This article has been cited by other articles:

				M. A. Lanaspa, A. Andres-Hernando, C. J. Rivard, Y. Dai, N. Li, and T. Berl ZAC1 Is Up-regulated by Hypertonicity and Decreases Sorbitol Dehydrogenase Expression, Allowing Accumulation of Sorbitol in Kidney Cells J. Biol. Chem., July 24, 2009; 284(30): 19974 - 19981. [Abstract] [Full Text] [PDF]

				T. Barz, A. Hoffmann, M. Panhuysen, and D. Spengler Peroxisome Proliferator-Activated Receptor {gamma} Is a Zac Target Gene Mediating Zac Antiproliferation Cancer Res., December 15, 2006; 66(24): 11975 - 11982. [Abstract] [Full Text] [PDF]

				A. Hoffmann, T. Barz, and D. Spengler Multitasking C2H2 Zinc Fingers Link Zac DNA Binding to Coordinated Regulation of p300-Histone Acetyltransferase Activity. Mol. Cell. Biol., July 1, 2006; 26(14): 5544 - 5557. [Abstract] [Full Text] [PDF]

				M. Theodoropoulou, J. Zhang, S. Laupheimer, M. Paez-Pereda, C. Erneux, T. Florio, U. Pagotto, and G. K. Stalla Octreotide, a Somatostatin Analogue, Mediates Its Antiproliferative Action in Pituitary Tumor Cells by Altering Phosphatidylinositol 3-Kinase Signaling and Inducing Zac1 Expression Cancer Res., February 1, 2006; 66(3): 1576 - 1582. [Abstract] [Full Text] [PDF]

				A. Contestabile, T. Fila, R. Bartesaghi, and E. Ciani Cyclic AMP-mediated Regulation of Transcription Factor Lot1 Expression in Cerebellar Granule Cells J. Biol. Chem., September 30, 2005; 280(39): 33541 - 33551. [Abstract] [Full Text] [PDF]

				E. Basyuk, V. Coulon, A. Le Digarcher, M. Coisy-Quivy, J.-P. Moles, A. Gandarillas, and L. Journot The Candidate Tumor Suppressor Gene ZAC Is Involved in Keratinocyte Differentiation and Its Expression Is Lost in Basal Cell Carcinomas Mol. Cancer Res., September 1, 2005; 3(9): 483 - 492. [Abstract] [Full Text] [PDF]

				M. O. Velardez, A. H. Poliandri, J. P. Cabilla, C. C. A. Bodo, L. I. Machiavelli, and B. H. Duvilanski Long-Term Treatment of Anterior Pituitary Cells with Nitric Oxide Induces Programmed Cell Death Endocrinology, April 1, 2004; 145(4): 2064 - 2070. [Abstract] [Full Text] [PDF]

				A. Hoffmann, E. Ciani, J. Boeckardt, F. Holsboer, L. Journot, and D. Spengler Transcriptional Activities of the Zinc Finger Protein Zac Are Differentially Controlled by DNA Binding Mol. Cell. Biol., February 1, 2003; 23(3): 988 - 1003. [Abstract] [Full Text]

				U. Pagotto, T. Arzberger, M. Theodoropoulou, Y. Grübler, C. Pantaloni, W. Saeger, M. Losa, L. Journot, G. K. Stalla, and D. Spengler The Expression of the Antiproliferative Gene ZAC Is Lost or Highly Reduced in Nonfunctioning Pituitary Adenomas Cancer Res., December 1, 2000; 60(24): 6794 - 6799. [Abstract] [Full Text]

				M. Kamiya, H. Judson, Y. Okazaki, M. Kusakabe, M. Muramatsu, S. Takada, N. Takagi, T. Arima, N. Wake, K. Kamimura, et al. The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes Hum. Mol. Genet., February 12, 2000; 9(3): 453 - 460. [Abstract] [Full Text] [PDF]

				Y. Maebayashi, Y. Shigeyoshi, T. Takumi, and H. Okamura A Putative Transcription Factor with Seven Zinc-Finger Motifs Identified in the Developing Suprachiasmatic Nucleus by the Differential Display PCR Method J. Neurosci., November 15, 1999; 19(22): 10176 - 10183. [Abstract] [Full Text] [PDF]